Not applicableUnknownNCT03815864What this trial is testingAntibodies and Liver RetransplantationWho this might be right forLiver Transplant FailureAntibody-mediated Rejection London Health Sciences Centre 200
Post-approval studies (Phase 4)Active Not RecruitingNCT07274462What this trial is testingDARA-MVI Study (Daratumumab for Microvascular Inflammation in Kidney Transplantation)Who this might be right forMicrovascular Inflammation - MVI in Kindey Transplant Recipients University Hospital, Martin 20
Not applicableStudy completedNCT03423901What this trial is testingImpact of Anti-HLA Donor-specific Antibodies in ABO-incompatible Kidney TransplantationWho this might be right forKidney Transplant University Hospital, Toulouse 58
Not applicableActive Not RecruitingNCT07316829What this trial is testingTRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiSWho this might be right forGraft RejectionKidney TransplantationLung Transplantation+6 more Fondazione IRCCS Policlinico San Matteo di Pavia 30
Not applicableStudy completedNCT05431712What this trial is testingImpact of Donor-Specific Antibodies in (Highly-) Immunized Living Donor Kidney Transplant RecipientsWho this might be right forRenal Failure Erasmus Medical Center 252
Early research (Phase 1)Ended earlyNCT01848301What this trial is testingEndothelial Injury and Development of Coronary Intimal Thickening After Heart TransplantationWho this might be right forCardiac Allograft VasculopathyAntibody Mediated Rejection Gladwin, Mark, MD 12
Testing effectiveness (Phase 2)Study completedNCT03380377What this trial is testingClazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney TransplantWho this might be right forAntibody-mediated RejectionKidney Transplant; ComplicationsTransplant Glomerulopathy+3 more Stanley Jordan, MD 10
Large-scale testing (Phase 3)Looking for participantsNCT04877288What this trial is testingEvaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive MedicationsWho this might be right forRenal Allograft Recipients Bristol-Myers Squibb 102
Post-approval studies (Phase 4)UnknownNCT04404127What this trial is testingStandard Induction With Basiliximab Versus No-Induction in Low Immunological Risk Kidney Transplant RecipientsWho this might be right forKidney Transplantation King Faisal Specialist Hospital & Research Center 140
Not applicableStudy completedNCT03438058What this trial is testingComplement-activating Anti-human Leucocyte Antigen Donor Specific Antibodies in Solid Organ TransplantationWho this might be right forOrgan Transplant Recipients Paris Translational Research Center for Organ Transplantation 7,547
Not applicableUnknownNCT03436134What this trial is testingTreatment of Chronic Active Antibody Mediated Rejection After Kidney Transplantation by Double-Filtration PlasmaPheresis or Plasma ExchangeWho this might be right forKidney TransplantationAntibody Mediated Rejection University Hospital, Grenoble 16
Testing effectiveness (Phase 2)UnknownNCT02563340What this trial is testingEffect of BM-MSCs on Chronic AMR After Kidney TransplantationWho this might be right forKidney Transplantation First Affiliated Hospital, Sun Yat-Sen University 60
Not applicableStudy completedNCT06425497What this trial is testingDE NOVO DONOR SPECIFIC ANTIBODIES AFTER KIDNEY TRANSPLANTATION: SINGLE-CENTER RETROSPECTIVE STUDYWho this might be right forKidney Transplant; ComplicationsImmunosuppression University of Rome Tor Vergata 600
Not applicableUnknownNCT03861962What this trial is testingRe-evaluation of Donor-specific Anti-HLA Alloantibodies Immunoassay After Organ Transplantation, From Antigen Level to Epitope LevelWho this might be right forOrgan Transplantation Assistance Publique - Hôpitaux de Paris 20,000
Not applicableEnded earlyNCT02133248What this trial is testingIdentification of Donor Specific B Cells and Antibody Mediated RejectionWho this might be right forSensitized Kidney Transplant Recipients University of Wisconsin, Madison 86
Post-approval studies (Phase 4)Study completedNCT04033276What this trial is testingIVIG/Rituximab vs Rituximab in Kidney Transplant With de Novo Donor-specific AntibodiesWho this might be right forRenal Transplant Seoul National University Hospital 50
Not applicableLooking for participantsNCT06025240What this trial is testingExpanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant RecipientsWho this might be right forKidney TransplantRenal Transplant FailureKidney Transplant Rejection+5 more Liverpool University Hospitals NHS Foundation Trust 282
Not applicableStudy completedNCT07200583What this trial is testingProtein A Immunoadsorption in Highly Sensitized Haplo-HSCT PatientsWho this might be right forHematologic MalignanciesHematologic DisordersAllogeneic Hematopoietic Stem Cell Transplantation (HSCT)+1 more Ting YANG 50
Early research (Phase 1)Not Yet RecruitingNCT06948097What this trial is testingSyk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific AntibodiesWho this might be right forLung Transplantation National Heart, Lung, and Blood Institute (NHLBI) 30
Post-approval studies (Phase 4)Study completedNCT01044303What this trial is testingReducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)Who this might be right forTransplant; Failure, Kidney East Carolina University 32